These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 1614285)

  • 21. Effects of vasopressin and angiotensin II on neurones in the rat dorsal motor nucleus of the vagus, in vitro.
    Mo ZL; Katafuchi T; Muratani H; Hori T
    J Physiol; 1992 Dec; 458():561-77. PubMed ID: 1302279
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Roles of intracellular and extracellular calcium in the kinetic profile of adrenocorticotropin secretion by perifused rat anterior pituitary cells. II. Arginine vasopressin, oxytocin, and angiotensin-II stimulation.
    Won JG; Oki Y; Orth DN
    Endocrinology; 1990 Feb; 126(2):858-68. PubMed ID: 2153530
    [TBL] [Abstract][Full Text] [Related]  

  • 23. kappa-Opioid agonist inhibition of osmotically induced AVP release: preferential action at hypothalamic sites.
    Rossi NF; Brooks DP
    Am J Physiol; 1996 Feb; 270(2 Pt 1):E367-72. PubMed ID: 8779961
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vivo and in vitro effects of arginine-vasopressin receptor antagonists on the hypothalamic-pituitary-adrenal axis in the rat.
    Bernardini R; Chiarenza A; Kamilaris TC; Renaud N; Lempereur L; Demitrack M; Gold PW; Chrousos GP
    Neuroendocrinology; 1994 Nov; 60(5):503-8. PubMed ID: 7845540
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ghrelin is released from rat hypothalamic explants and stimulates corticotrophin-releasing hormone and arginine-vasopressin.
    Mozid AM; Tringali G; Forsling ML; Hendricks MS; Ajodha S; Edwards R; Navarra P; Grossman AB; Korbonits M
    Horm Metab Res; 2003 Aug; 35(8):455-9. PubMed ID: 12953161
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dopaminergic control of angiotensin II-induced vasopressin secretion in vitro.
    Rossi NF
    Am J Physiol; 1998 Oct; 275(4):E687-93. PubMed ID: 9755089
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of chronic intracerebroventricular angiotensin II infusion on vasopressin release in rats.
    Sterling GH; Chee O; Riggs RV; Keil LC
    Neuroendocrinology; 1980 Sep; 31(3):182-8. PubMed ID: 7413018
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased motor disturbances in response to arginine vasopressin following hemorrhage or hypertonic saline: evidence for central AVP release in rats.
    Burnard DM; Pittman QJ; Veale WL
    Brain Res; 1983 Aug; 273(1):59-65. PubMed ID: 6616233
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pituitary binding of vasopressin is altered by experimental manipulations of the hypothalamo-pituitary-adrenocortical axis in normal as well as homozygous (di/di) Brattleboro rats.
    Antoni FA; Holmes MC; Kiss JZ
    Endocrinology; 1985 Oct; 117(4):1293-9. PubMed ID: 3161722
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential response of renin secretion to vasoconstrictors in the isolated perfused rat kidney.
    Scholz H; Kaissling B; Inagami T; Kurtz A
    J Physiol; 1991 Sep; 441():453-68. PubMed ID: 1816382
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of dopamine on neurohypophysial hormone release in vivo and from the rat neural lobe and hypothalamus in vitro.
    Bridges TE; Hillhouse EW; Jones MT
    J Physiol; 1976 Sep; 260(3):647-66. PubMed ID: 988183
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Control of posterior pituitary vasopressin content: implications for the regulation of the vasopressin gene.
    Fitzsimmons MD; Roberts MM; Robinson AG
    Endocrinology; 1994 Apr; 134(4):1874-8. PubMed ID: 8137755
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Localization of central sites of action of angiotensin II on ADH release in vitro.
    Gregg CM; Malvin RL
    Am J Physiol; 1978 Feb; 234(2):F135-40. PubMed ID: 623304
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential effects of endotoxaemia on pressor and vasoconstrictor actions of angiotensin II and arginine vasopressin in conscious rats.
    Tarpey SB; Bennett T; Randall MD; Gardiner SM
    Br J Pharmacol; 1998 Apr; 123(7):1367-74. PubMed ID: 9579732
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of glucocorticoids on vascular reactivity to vasoactive hormones in rat isolated kidney: lack of relationship to prostaglandins.
    Cooper CL; Malik KU
    Br J Pharmacol; 1984 Jul; 82(3):679-88. PubMed ID: 6589024
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impaired regulation of neurohypophyseal vasopressin secretion in rats treated neonatally with monosodium-L-glutamate.
    Gerstberger R; DiPaolo T; Barden N
    Neurosci Lett; 1987 Oct; 81(1-2):193-8. PubMed ID: 2827065
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ontogeny of opioid inhibition of vasopressin and oxytocin release in response to osmotic stimulation.
    Hartman RD; Rosella-Dampman LM; Emmert SE; Summy-Long JY
    Endocrinology; 1986 Jul; 119(1):1-11. PubMed ID: 3720659
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Formation of angiotensin II and other angiotensin peptides from des-leu 10-angiotensin I in rat lung and kidney.
    Drummer OH; Kourtis S; Johnson H
    Biochem Pharmacol; 1988 Nov; 37(22):4327-33. PubMed ID: 2848526
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evidence for an inhibitory effect of nitric oxides on neuropeptide secretion from isolated neural lobe of the rat pituitary gland.
    Lutz-Bucher B; Koch B
    Neurosci Lett; 1994 Jan; 165(1-2):48-50. PubMed ID: 7517025
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Angiotensin II sensitive neurons in the supraoptic nucleus, subfornical organ and anteroventral third ventricle of rats in vitro.
    Okuya S; Inenaga K; Kaneko T; Yamashita H
    Brain Res; 1987 Jan; 402(1):58-67. PubMed ID: 3030493
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.